Luke Timmerman, a respected biotechnology journalist known for his past work at The Seattle Times and Xconomy, today launched a new subscription-based biotech news site, The Timmerman Report.
The debut comes as Timmerman puts the finishing touches on the book he has been writing about biotech pioneer Lee Hood.
“It has been a wonderful reporting challenge putting such a complicated life under the microscope,” writes Timmerman in his introductory post, “But I have missed the action of day-to-day journalism. It’s my passion. We’re living in a wonderfully creative time for biotech, and it’s a privilege to write about it.”
Timmerman remains based in Seattle, but the site will cover biotech news with a national perspective, as well. Readers can subscribe for $99/year, with a special $25/year rate available to graduate and post-doctoral students.
For more, also check out Timmerman’s recent appearance on the GeekWire radio show, talking about the latest news from the biotech industry.
